The IDN Pharmacy supply chain plays a vital role in patient outcomes. IDN pharmacy executives continue to look for innovative methods of improving quality while keeping costs low. Nonetheless, concerns facing the pharmacy segment of healthcare are highly nuanced and complex. This track will prepare you for 2026 and beyond as you examine critical topics from 340B compliance to ensuring revenue integrity facing supply chain leaders and pharmacy executives alike.
Pharmacy Revenue Track is from 1:00 PM to 5:00 PM on Monday, August 25. For more information contact Trey Beuttel or call 859.523.5701
1:00 PM - 2:00 PM | The gap between pharmacy and finance has never been more critical—or more complex. As drug costs rise and reimbursement pressures increase, the alignment between pharmacy operations and financial strategy is essential to both fiscal sustainability and patient access. Yet, many organizations still struggle with communication obstacles, misaligned priorities, and unclear ownership over cost and margin management.
Join pharmacy leaders and explore the often-blurred lines between pharmacy and finance, highlighting how collaboration can be strengthened to drive shared goals and bridge the gap between these two critical departments.
Learning Objectives: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2:30 PM - 3:30 PM | As legal scrutiny and regulatory uncertainty continue to surround the topic of 340B, pharmacy leaders must stay up to date on the latest developments to protect program integrity and ensure compliance. The policy landscape is shifting all the time, with changes to contract pharmacy arrangements, manufacturer restrictions, and audit practices reshaping how 340B is implemented across IDNs.
Join Mark Ogunsusi and explore a timely update on the evolution and advancement of 340B, its impact on your organization, and strategies for adapting to a program that continues to face intense external pressure.
Learning Objectives: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4:00 PM - 5:00 PM | Navigating the complex web of payors, prior authorization processes, and pharmacy benefit managers (PBMs) has become a daily operational challenge for pharmacy leaders across IDNs. These three forces significantly impact patient access, drug reimbursement, and the overall efficiency of pharmacy services – often in ways that can be misaligned with clinical and financial goals.
Join pharmacy experts and break down how each “P” influences pharmacy operations and revenue cycles, providing real-world insights into policy trends, payor negotiations, and authorization barriers.
Learning Objectives: |
For more information on the 2025 Fall Summit, please contact Trey Beuttel.
Trey Beuttel
Director, Provider Relationships and Education
859.523.5701